Dana Farber Mass General Brigham Cancer Care Inc
- Assets
- $42.6m
- Revenue
- $95.2m
- Investments
- $0.0
- Employees
- 0
- Location
- Boston, MA
- Founding
- 04/1998
- Data as of
- 09/2021
- EIN
- 04-3320640
Organization Overview
Dana Farber Mass General Brigham Cancer Care Inc is located in Boston, MA. The organization was established in 1998. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Dana Farber Mass General Brigham Cancer Care Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2021, Dana Farber Mass General Brigham Cancer Care Inc generated $95.2m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 6.1% each year. All expenses for the organization totaled $96.0m during the year ending 09/2021. While expenses have increased by 6.2% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
COORDINATION OF ONCOLOGY CLINICAL RESEARCH, EDUCATION, AND PROGRAMS ACROSS DANA-FARBER, MASSACHUSETTS GENERAL HOSPITAL, AND BRIGHAM AND WOMEN'S HOSPITAL.
Describe the Organization's Program Activity:
Part 3 - Line 4a
CLINICAL TRIAL STUDIES AND RESEARCH RELATED TO INVESTIGATING NEW MEDICATIONS AND METHODS OF TREATMENT OF CANCER, WITH HOPE OF FINDING A CURE.
EDUCATIONAL PROGRAMS FOR CLINICIANS AND RESEARCHERS WITH A FOCUS ON THE DF/MGH HEMATOLOGY ONCOLOGY FELLOWSHIP PROGRAM.
DEVELOPMENT OF CLINICAL GUIDELINES, PROTOCOLS, AND STANDARDS OF CARE FOR THE TREATMENT OF CANCER, AS WELL AS ESTABLISHING PRIORITIES FOR RESEARCH.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Ramesh A Shivdasani MD Trustee And President | OfficerTrustee | 2 | $0 |
Sally Mason Boemer Treasurer | Officer | 1 | $0 |
Ellen Farwell ESQ Clerk (end 06/10/21) | Officer | 1 | $0 |
John Ryan ESQ Clerk (as Of 7/19/21) | Officer | 1 | $0 |
David P Ryan MD Trustee | Trustee | 1 | $0 |
Ravi I Thadhani MD MPH Trustee | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Dana-farber Cancer Institute Inc Research Services | 9/29/21 | $53,285,589 |
Brigham And Women's Hospital Research Services | 9/29/21 | $3,831,784 |
Beth Israel Deaconess Medical Cente Research Services | 9/29/21 | $3,101,614 |
Massachusetts General Hospital Research Services | 9/29/21 | $31,593,165 |
Mass General Brigham Inc Information Systems | 9/29/21 | $167,718 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $95,108,873 |
| Investment income | $77,495 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $95,186,368 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $484,289 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $116,229 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $29,000 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $95,244,274 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $144,800 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $587 |
| Total functional expenses | $96,019,179 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $27,353,102 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $9,989 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $11,850,471 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $3,433,927 |
| Total assets | $42,647,489 |
| Accounts payable and accrued expenses | $29,641 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $30,870,233 |
| Total liabilities | $30,899,874 |
| Net assets without donor restrictions | $11,747,615 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $42,647,489 |
Grants Recieved
Over the last fiscal year, we have identified 6 grants that Dana Farber Mass General Brigham Cancer Care Inc has recieved totaling $197,306.
| Awarding Organization | Amount |
|---|---|
National Comprehensive Cancer Network Inc Plymouth Meeting, PA PURPOSE: RESEARCH | $184,927 |
Analog Devices Foundation Boston, MA PURPOSE: GENERAL SUPPORT | $6,226 |
Amica Companies Foundation Lincoln, RI PURPOSE: GENERAL PURPOSE | $4,550 |
Andrassy Family Foundation Inc Palm Beach, FL PURPOSE: GENERAL PURPOSE | $1,000 |
Frisbie Family Foundation Boston, MA PURPOSE: CHARITABLE | $500 |
Analog Devices Foundation Boston, MA PURPOSE: GENERAL SUPPORT | $103 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Dana Farber Mass General Brigham Cancer Care Inc Boston, MA | $42,647,489 | $95,186,368 |
Ludwig Institute For Cancer Research New York, NY | $25,811,385 | $89,264,708 |
Cancer Research Institute Inc New York, NY | $130,438,312 | $33,675,150 |
Lake Champlain Cancer Research Org Inc Essex Jct, VT | $0 | $292,033 |
Addgene Inc Watertown, MA | $22,116,271 | $23,985,910 |
Count Me In Inc Cambridge, MA | $7,331,909 | $8,017,841 |
Lung Cancer Research Foundation New York, NY | $5,738,095 | $6,154,252 |
The Ricbac Foundation Newtonville, MA | $46,150,580 | $5,404,964 |
Samuel Waxman Cancer Research Foundation New York, NY | $4,834,675 | $2,510,809 |
Advanced Medical Research Foundation Inc Brookline, MA | $69,323,551 | $6,501,514 |
International Myeloma Society Needham, MA | $7,371,497 | $4,469,545 |
Laniado Development Fund Inc Monsey, NY | $541,683 | $1,706,128 |